Geoffrey M. Nichol
2014
In 2014, Geoffrey M. Nichol earned a total compensation of $1.8M as Former Executive Vice President, Research and Development at Sangamo Biosciences, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,300 |
|---|---|
| Option Awards | $607,343 |
| Salary | $460,000 |
| Stock Awards | $527,625 |
| Total | $1,781,268 |
Nichol received $607.3K in option awards, accounting for 34% of the total pay in 2014.
Nichol also received $186.3K in non-equity incentive plan, $460K in salary and $527.6K in stock awards.
Rankings
In 2014, Geoffrey M. Nichol's compensation ranked 4,995th out of 13,032 executives tracked by ExecPay. In other words, Nichol earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,995 out of 13,032 | 62nd |
Division Manufacturing | 1,780 out of 4,965 | 64th |
Major group Chemicals And Allied Products | 587 out of 1,690 | 65th |
Industry group Drugs | 447 out of 1,369 | 67th |
Industry Biological Products, Except Diagnostic Substances | 75 out of 241 | 69th |
Source: SEC filing on April 25, 2017.
Nichol's colleagues
We found four more compensation records of executives who worked with Geoffrey M. Nichol at Sangamo Biosciences in 2014.